Dissecting the cellular heterogeneity of epileptogenic zones
J
Jignesh Tailor
Primary Investigator
Enrolling By Invitation
17 years or below
All
Phase
N/A
1 Location
Brief description of study
Researchers are hoping to discover new biomarkers to help doctors accurately locate seizure onset zones. Surgeons could use this knowledge to treat medically refractory epilepsy. This study's goal is to take the first step towards finding these biomarkers by learning more about the molecules and cells of people who have medically refractory epilepsy.
Detailed description of study
Researchers will obtain consent from the patient or guardian before any samples are used in research. Researchers will collect a sample from the tissue removed during surgery. They will collect some health data from participants for 5 years after the surgery.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: epilepsy, Riley
-
Age: 17 years or below
-
Gender: All
Inclusion Criteria:
- Presence of seizures
- Undergoing surgical resection
Exclusion Criteria:
- Over 18 at the time of the surgery
Updated on
14 Sep 2024.
Study ID: 14691, SNEU-IIR-EPILEPTOGENIC-ZONES
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
